CoChat
Sign Up
Cited by 12

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study

Sallam, Malik, Kherfan, Tleen, Al‐Farajat, Amwaj, Nemrawi, Leen, Atawneh, Nada, Fram, Rand, Al‐Tammemi, Ala'a B., Barakat, Muna, Fram, Kamil·2025·Health Science Reports
DOI 10.1002/hsr2.70319
Open this paper in CoChat — free account

Abstract

Background and Aims: The recently approved maternal vaccination against respiratory syncytial virus (RSV) can reduce its burden among infants. However, vaccine hesitancy/resistance can undermine the beneficial impact of RSV vaccination. The aim of this study was to assess the willingness of pregnant women in Jordan to receive RSV vaccination and its associated determinants. Methods: Face‐to‐face interviews were conducted in obstetrics/gynecology clinics in the Central, Northern, and Southern regions of Jordan during January–February 2024, using a convenience sampling approach. Attitude to RSV vaccination was assessed using the previously validated ABCDEF scale. Results: A total of 404 pregnant women participated in the study with a mean age of 30.1 ± 6.2 years. A majority of the participants showed willingness to receive RSV vaccination ( n = 313, 77.5%), with hesitancy among 25 participants (6.2%), and resistance among 66 participants (16.3%). Variables that were significantly associated with a higher RSV vaccine acceptance in multivariate analysis were: age < 30 years (adjusted odds ratio (aOR): 2.45, p = 0.010), undergraduates (aOR: 3.27, p = 0.026), being a healthcare worker (aOR: 4.50, p = 0.036), and the history of previous COVID‐19/influenza vaccine uptake (aOR: 2.47, p = 0.045). Two out of the six ABCDEF constructs were significantly associated with RSV vaccine acceptance, namely the “Advice” construct (aOR: 10.38, p < 0.001) and the “Fear” construct (aOR: 21.49, p < 0.001). Conclusion: This study highlighted the complex nature of attitude towards maternal RSV vaccination among pregnant women. The study showed the role of demographic variables, prior vaccination experience, trust in credible health institutions and vaccine safety, and the fear of RSV disease consequences in infants in shaping maternal attitude to RSV vaccination. Addressing these factors can help to effectively promote RSV vaccine uptake among pregnant women, subsequently helping to protect infants from the significant RSV disease burden.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hsr2.70319

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 72

  1. 10.1097/qco.0000000000000952 · DOI
  2. 10.1016/s0140-6736(22)00478-0 · DOI
  3. 10.1016/s0140-6736(17)30938-8 · DOI
  4. 10.1016/s0140-6736(24)00138-7 · DOI
  5. 10.1016/s2213-2600(20)30322-2 · DOI
  6. 10.1080/21645515.2022.2079322 · DOI
  7. 10.1007/s40121-018-0188-z · DOI
  8. 10.1016/s2468-2667(17)30103-2 · DOI
  9. 10.3389/fimmu.2023.1329426 · DOI
  10. 10.1056/NEJMoa2216480 · DOI · Paper page
  11. 10.1056/NEJMoa2213836 · DOI
  12. 10.1007/s40272-023-00598-3 · DOI
  13. 10.1016/j.lanepe.2023.100829 · DOI
  14. 10.1186/s12916-023-02806-w · DOI
  15. 10.3389/fimmu.2022.880368 · DOI
  16. 10.3390/vaccines11081386 · DOI · Paper page
  17. 10.1038/s41598-024-55867-z · DOI
  18. 10.1080/08870446.2023.2214569 · DOI
  19. 10.1016/j.vaccine.2023.05.047 · DOI
  20. 10.4161/hv.24657 · DOI
  21. 10.1371/journal.pone.0208601 · DOI
  22. 10.1016/j.vaccine.2015.11.065 · DOI
  23. 10.1186/s40001-021-00584-w · DOI
  24. 10.3389/fpubh.2024.1286891 · DOI
  25. 10.1016/j.pcl.2022.11.004 · DOI
  26. 10.1159/000538346 · DOI
  27. 10.1080/21645515.2019.1698901 · DOI
  28. 10.1186/s12884-023-05958-y · DOI
  29. 10.1016/j.vaccine.2020.10.051 · DOI
  30. 10.2147/jmdh.S347669 · DOI
  31. 10.1136/bmj.39335.541782.AD · DOI · Paper page
  32. 10.1016/j.edurev.2010.12.001 · DOI
  33. 10.5296/jse.v4i1.5088 · DOI
  34. 10.1111/bju.14640 · DOI
  35. 10.1016/j.cmi.2024.03.014 · DOI
  36. 10.31729/jnma.8622 · DOI · Paper page
  37. 10.1002/iid3.1257 · DOI · Paper page
  38. 10.1016/j.vaccine.2015.08.046 · DOI
  39. 10.1080/21645515.2022.2064686 · DOI
  40. 10.1016/j.jvacx.2023.100387 · DOI
  41. 10.1371/journal.pone.0272273 · DOI
  42. 10.3390/medicina57090977 · DOI
  43. 10.1017/dmp.2023.142 · DOI
  44. 10.2174/18744346-v17-e20230711-2023-61 · DOI
  45. 10.1371/journal.pone.0286289 · DOI
  46. 10.1016/j.vaccine.2014.06.067 · DOI
  47. 10.3390/ijerph14121551 · DOI
  48. 10.1016/j.vaccine.2013.08.063 · DOI
  49. 10.1016/S2666-5247(23)00195-7 · DOI
  50. 10.3390/pathogens12101259 · DOI
  51. 10.15585/mmwr.mm7241e1 · DOI
  52. 10.1007/s40272-023-00606-6 · DOI
  53. 10.7189/jogh.05.020416 · DOI
  54. 10.1093/jpids/piad098 · DOI
  55. 10.1136/bmjopen-2020-044903 · DOI
  56. 10.1186/s12884-023-05958-y · DOI
  57. 10.1080/21645515.2020.1740559 · DOI
  58. 10.1016/j.vaccine.2020.07.072 · DOI
  59. 10.1186/s12889-021-11184-y · DOI
  60. 10.1089/jwh.2020.8860 · DOI
  61. 10.1080/14767058.2023.2250894 · DOI
  62. 10.1186/1471-2393-12-100 · DOI
  63. 10.3390/vaccines11050897 · DOI
  64. 10.1080/21645515.2023.2258580 · DOI
  65. 10.1177/1090198120915432 · DOI
  66. 10.1186/s12889-023-16317-z · DOI
  67. 10.3390/vaccines11081387 · DOI
  68. 10.1016/j.vaccine.2023.05.024 · DOI
  69. 10.1080/21645515.2022.2127561 · DOI
  70. 10.1186/s12884-024-06425-y · DOI
  71. 10.1080/21645515.2024.2314826 · DOI
  72. 10.1016/j.vaccine.2022.06.055 · DOI

Metadata

Authors
Sallam, M., Kherfan, T., Al‐Farajat, A., Nemrawi, L., Atawneh, N., Fram, R., Al‐Tammemi, A. B., Barakat, M., & Fram, K.
Venue
Health Science Reports
Publisher
Wiley
Published
2025-01
Volume
8
Issue
1
ISSN
2398-8835
DOI
10.1002/hsr2.70319
Cited by
12
References
6
Language
en
Licence
creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 6 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study. https://app.cochat.ai/papers/10.1002/hsr2.70319
The paper
Sallam, M., Kherfan, T., Al‐Farajat, A., Nemrawi, L., Atawneh, N., Fram, R., Al‐Tammemi, A. B., Barakat, M., & Fram, K. (2025). Attitude to RSV Vaccination Among a Cohort of Pregnant Women in Jordan: A Cross‐Sectional Survey Study. Health Science Reports. https://doi.org/10.1002/hsr2.70319